Integrative Oncology for High-Grade Glioma: A Case Report on the Combined Effects of Oncothermia and Complementary Therapies.
Nair PM, Ramalakshmi R, Devibala M, Saranya M, Sivaranjini S, Thangavelu R, Mahalingam M · Cureus · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Integrative Oncology for High-Grade Glioma: A Case Report on the Combined Effects of Oncothermia and Complementary Therapies.” is organized in H2HUBB under the research focus hydrogen inhalation cancer supportive study 2024 nair. The publication is cited as Nair PM, Ramalakshmi R, Devibala M, Saranya M, Sivaranjini S, Thangavelu R, Mahalingam M, Cureus, 2024. This case report or case series examined Integrative Oncology for High-Grade Glioma: A Case Report on the Combined Effects of Oncothermia and Complementary Therapies. The abstract describes Human participants; hydrogen delivered as hydrogen inhalation; reported duration 24 days. The abstract reports: MRI scans before and after treatment showed a reduction in tumor size from 3.6 x 2.9 x 2.5 cm to 3.4 x 2.7 x…. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen inhalation cancer supportive study 2024 nair overview
The main outcome was not fully reported in the available structured record and should be checked against the original source. Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.
Study design and hydrogen intervention
Publication type: Case report or case series. Evidence type: Human clinical evidence. Research model or population: Human participants. Randomized: Yes. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen inhalation. Treatment duration: 24 days.
Reported findings and scientific interpretation
For this hydrogen inhalation cancer supportive study 2024 nair, the study record reports the following: The abstract reports: MRI scans before and after treatment showed a reduction in tumor size from 3.6 x 2.9 x 2.5 cm to 3.4 x 2.7 x…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Case-report evidence cannot establish causality or broad generalizability.
The intervention or follow-up period appears relatively short.
Further research, including randomized controlled trials, is necessary to validate these findings and determine the specific contributions of each therapy.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.